Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / CCL15

CCL15

Basics

Aliases:
This biomarker is also known as:
  • Mrp-2b,
  • Macrophage inflammatory protein 5,
  • LKN-1,
  • chemokine CC-2,
  • Leukotactin-1,
  • MIP-1D,
  • MIP-1d,
  • LKN1,
  • MIP-1 delta,
  • MRP-2B,
  • HCC-2,
  • NCC3,
  • MIP-5,
  • chemokine (C-C motif) ligand 15,
  • Lkn-1,
  • small-inducible cytokine A15,
  • leukotactin 1,
  • SY15,
  • Chemokine CC-2,
  • macrophage inflammatory protein 5,
  • MIP5,
  • C-C motif chemokine 15,
  • NCC-3,
  • small inducible cytokine subfamily A (Cys-Cys), member 15,
  • HMRP-2B,
  • SCYA15,
  • Small-inducible cytokine A15,
  • new CC chemokine 3,
  • SCYL3,

View in BioMuta

Description…

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: CCL15

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.